Let's get really contrarian.
Let's get really contrarian and take a look at some of the smallest funds in the Morningstar 500. They're being ignored by fund investors, but they've really got a lot to like.
Queens Road Small Cap Value
Manager Steve Scruggs has done a great job of deep value investing at this fund, as its 4-star Morningstar Rating indicates. He's produced great results since the fund was launched in 2002. Its return on $10,000 since that time is $25,500 versus $20,100 for the average small-value fund. Yet, with an asset base of just $57 million, the fund has plenty of flexibility to buy the neglected small-cap names it covets.
Scruggs looks for companies dominating their niche, such as publisher Scholastic
This mutual fund was launched in 2005 and it is still just a $51 million fund, but it's no dog. Charles Bobrinskoy and Tim Fidler apply Ariel's approach to large caps. As the name makes clear, they are keeping the fund in a concentrated basket of 24 stocks. Can Ariel's emphasis on stable, low-valuation companies work in a focused large-cap fund? I think so. The emphasis on stability has kept volatility roughly in line with other large-blend funds despite the concentration. Moreover, large-cap stocks appear to be relatively cheap these days, so it's a strategy that should work well. Interestingly, the portfolio of fiscally strong but cheap stocks held up much better than did Ariel
Masters Select Focused Opportunities
Now, this fund really counts as contrarian. It has a Morningstar rating of 1 star, and its 20-stock portfolio has added up to high risk even though its picks come from three different firms plying three very different strategies. That diversity of strategies is supposed to tone down the volatility of a focused portfolio, but the three firms have collectively leaned heavily toward financials and energy, two of the market's more volatile sectors.
If you're still reading, here's why this fund is a pretty good bet: Chris Davis and Ken Feinberg are excellent managers who just went through their worst three-year stretch on record. That's not likely to happen again. I also like Mutual Series' Philippe Brugere-Trelat and Peter Langerman. They're seasoned investors who bring a welcome note of conservatism to the fund. Finally, the third sleeve is run by Frank Sands Jr. and Michael Sramek of Sands Capital. The pair runs a low-turnover high-growth strategy that has had a headwind for most of the past 10 years. That's not likely to continue, and this fund could well have a bright future. My only gripe is that the expense ratio is on the high side, but it can come down with asset growth.
This fund has a mere $11 million in assets and a 2-star rating, so it's understandable that people would pass it over, but there's more there than meets the eye.